812
Participants
Start Date
October 8, 2021
Primary Completion Date
October 14, 2024
Study Completion Date
October 23, 2024
Lumateperone
Lumateperone 42 mg capsules administered orally, once daily
Clinical Site, Budapest
Clinical Site, Budapest
Clinical Site, Budapest
Clinical Site, Budapest
Clinical Site, Novi Iskar
Clinical Site, Sofia
Clinical Site, Sofia
Clinical Site, Vratsa
Clinical Site, Gyöngyös
Clinical Site, Plovdiv
Clinical Site, Debrecen
Clinical Site, Veliko Tarnovo
Clinical Site, Veliko Tarnovo
Clinical Site, Pleven
Clinical Site, Kazanlak
Clinical Site, Rousse
Clinical Site, Targovishte
Clinical Site, Burgas
Clinical Site, Tsarev Brod
Clinical Site, Mount Kisco
Clinical Site, Brooklyn
Clinical Site, Stockholm
Clinical Site, Cedarhurst
Clinical Site, Ansan-si
Clinical Site, Allentown
Clinical Site, Schwerin
Clinical Site, Media
Clinical Site, Plymouth Meeting
Clinical Site, Hamburg
Clinical Site, Gaithersburg
Clinical Site, Lund
Clinical Site, Westerstede
Clinical Site, Charlotte
Clinical Site, Decatur
Clinical Site, Atlanta
Clinical Site, Atlanta
Clinical Site, Atlanta
Clinical Site, Jacksonville
Clinical Site, Orlando
Clinical Site, Palm Bay
Clinical Site, Fort Lauderdale
Clinical Site, West Palm Beach
Clinical Site, Flowood
Clinical Site, Brno
Clinical Site, Joliet
Clinical Site, Bad Homburg
Clinical Site, Gwangju
Clinical Site, Saint Charles
Clinical Site, Overland Park
Clinical Site, Little Rock
Clinical Site, Bentonville
Clinical Site, Rogers
Clinical Site, Austin
Clinical Site, Freiburg im Breisgau
Clinical Site, Bratislava
Clinical Site, Phoenix
Clinical Site, Oulu
Clinical Site, Culver City
Clinical Site, Glendale
Clinical Site, Sherman Oaks
Clinical Site, Upland
Clinical Site, Oceanside
Clinical Site, San Diego
Clinical Site, Redlands
Clinical Site, Riverside
Clinical Site, Newport Beach
Clinical Site, Temecula
Clinical Site, Bellevue
Clinical Site, Jūnāgadh
Clinical Site, Ahmedabad
Clinical Site, Vadodara
Clinical Site, Mumbai
Clinical Site, Nashik
Clinical Site, Nashik
Clinical Site, Aurangabad
Clinical Site, Nagpur
Clinical Site, Mysore
Clinical Site, Guwahati
Clinical Site, Boston
Clinical Site, Berlin
Clinical Site, Toms River
Clinical site, Brno
Clinical Site, Hostivice
Clinical Site, Ostrava
Clinical Site, Pilsen
Clinical Site, Prague
Clinical Site, Prague
Clinical Site, Prague
Clinical Site, Helsinki
Clinical Site, Mittweida
Clinical Site, Bełchatów
Clinical Site, Bialystok
Clinical Site, Bialystok
Clinical Site, Bialystok
Clinical Site, Bydgoszcz
Clinical Site, Gdansk
Clinical Site, Gorlice
Clinical Site, Leszno
Clinical Site, Pruszcz Gdański
Clinical SIte, Torun
Clinical Site, Wroclaw
Clinical Site, Košice
Clinical Site, Rimavská Sobota
Clinical Site, Svidník
Clinical Site, Vranov nad Topľou
Clinical Site, Zlaté Moravce
Clinical Site, Seoul
Clinical Site, Seoul
Clinical Site, Seoul
Lead Sponsor
Intra-Cellular Therapies, Inc.
INDUSTRY